Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
about
The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophagesFungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitroCryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in micePhenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans.The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibodySusceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro.Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformansNon-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharidePhagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophagesEvidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans.The role of host gender in the pathogenesis of Cryptococcus neoformans infections.Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry.Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytesCapsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infectionCryptococcal genotype influences immunologic response and human clinical outcome after meningitis.Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.Cryptococcal capsular polysaccharide-induced modulation of murine immune responses.Immediate hypersensitivity to Cryptococcus neoformansOpsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicityThe glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigenGalactoxylomannans of Cryptococcus neoformans.Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responsesDifferential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.Activation and binding of C3 by Candida albicans.Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa
P2860
Q24561597-C229CD6D-D37D-4E2E-8230-D0BC46D9F36FQ28369533-D172C36C-E5EC-464F-87E1-E5943EF51C62Q30424017-6166CBE3-DAC7-45AD-A0AD-099349C3EC0DQ33762293-04CD2C7A-2316-479E-A1B4-1C304DC6AA44Q33905575-2DB10073-DB72-42FD-99C5-4E4B06929FAEQ33906829-9BA5869B-96D4-42AE-A1D4-187C7AAEA6FBQ33913191-AD7B0541-2DCD-4372-87BE-3963BE170C56Q34001769-167CC509-B6FE-4DCA-B3F9-80D834C7136FQ34006152-BA8D95E7-75B2-4E42-9F17-EB7D422A9827Q34088603-9651DF6B-1B8D-4F68-B2AB-FDD6E8401364Q34088651-1FD975A6-716E-41D8-B9D4-B971EAB5A431Q34096432-DC193AFB-AE7E-467B-99BF-293EE2DD651EQ34429542-D2226B86-EECA-409E-9ACE-E532324188E5Q34454156-1C47B2BA-6708-44D5-B68E-2EF7ADC122EFQ34561087-53581C7A-E929-4F7F-8FFE-1CF252C8E256Q34681238-D94FD80C-A717-4930-A24B-E310C302E1D1Q34718557-DA501F93-C235-4D87-B8B5-3A4414920EE0Q34760386-1AC2CE10-3EC9-4525-BAD6-D947FD742F85Q35225136-F761A6C6-1464-49F4-9905-FF8CAB38A038Q35427625-34CE8C87-DCFB-433A-9827-9C700D53115CQ35508763-12F988C6-C497-4429-B268-A5FCE27957D1Q36042949-3CC5EB47-005F-4374-ABE8-FDC3C5B25250Q36250573-93F4CDDA-F335-4A26-B9F5-0DF5B7DDEFFAQ36346286-B93C7D4C-C35D-4AC0-98F0-C2B25AFCCEBEQ36438826-6F829A08-6549-4660-9D40-D05A90FE614AQ36443790-A394C1C6-2FE5-42A3-91BD-A59266E0E62DQ36444623-C56EE854-5FB7-43C0-BC55-51172671A557Q36517209-7A25BD5A-B8AE-4E14-A74D-79280AEA72A9Q36951576-609E9C94-E3FE-4EAC-9F7F-D6F38466433DQ36956261-C3FCF46D-8A45-461D-A114-06D718CA43B8Q36958708-E90256C3-C9B8-48F3-9C61-1AF9ECD5B3B6Q36988622-725E8C2F-24C2-4DA7-BAC1-8877CDB0A030Q36999560-0298FABB-8258-4B6F-B308-B38A1A83613EQ37000442-D70B0353-9BF5-48F4-BB87-42EE21783B53Q37005496-0CB5B8CA-04C8-4028-816C-7D15699E1CE2Q37007244-317C9E77-F848-410D-8DE8-90F4A0816A54Q37013969-B524D35A-0A7F-48EE-A28D-71734F319680Q37021874-BFD89542-7C6B-4078-846D-A6867820F0C7Q37021882-1FEC8CA0-2B89-4E2C-995A-45EB7DE63C08Q37028395-FBE845A4-8576-4B4A-B29B-59281E0DCDBF
P2860
Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Inhibition of phagocytosis by ...... estion phases of phagocytosis.
@en
type
label
Inhibition of phagocytosis by ...... estion phases of phagocytosis.
@en
prefLabel
Inhibition of phagocytosis by ...... estion phases of phagocytosis.
@en
P2860
P1476
Inhibition of phagocytosis by ...... gestion phases of phagocytosis
@en
P2093
Mastroianni RP
P2860
P407
P577
1976-07-01T00:00:00Z